eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/12/2011
PIL Lyrinel XL prolonged release tablet.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 22/07/2011 and displayed until 21/12/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/07/2011 and displayed until 22/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 01/12/2010 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to storage instructions
Updated on 25/09/2009 and displayed until 01/12/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 01/08/2008 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to drug interactions
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 07/11/2006 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
Updated on 17/11/2005 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 13/08/2004 and displayed until 17/11/2005
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 13/07/2004 and displayed until 13/08/2004
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to storage instructions
Updated on 23/05/2003 and displayed until 13/07/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  oxybutynin hydrochloride